Profile
| Role | Chairman & CEO, Director |
|---|
Updated Jul 16, 2026
O'Day Daniel Patrick has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $46.83M.
| Role | Chairman & CEO, Director |
|---|
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale | 3.1K | $127.08 | $394K |
| 2026-07-02 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale | 11.9K | $126.09 | $1.50M |
| 2026-06-11 | GILD | GILEAD SCIENCES, INC. | F — Tax withholding / forfeiture | 4.2K | $121.48 | $512K |
| 2026-06-11 | GILD | GILEAD SCIENCES, INC. | M — Option exercise | 8.8K | — | |
| 2026-06-02 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale | 1.0K | $132.97 | $138K |
| 2026-06-02 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale | 3.1K | $132.22 | $405K |
| 2026-06-02 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale | 10.9K | $131.10 | $1.43M |
| 2026-04-29 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale | 3.0K | $130.01 | $397K |
| 2026-04-29 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale | 7.0K | $128.79 | $895K |
| 2026-03-30 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale [10b5-1] | 10.0K | $136.82 | $1.37M |
| 2026-03-12 | GILD | GILEAD SCIENCES, INC. | F — Tax withholding / forfeiture | 9.8K | $148.56 | $1.45M |
| 2026-03-12 | GILD | GILEAD SCIENCES, INC. | M — Option exercise | 20.0K | — | |
| 2026-03-02 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale [10b5-1] | 100 | $145.71 | $15K |
| 2026-03-02 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale [10b5-1] | 6.4K | $145.18 | $932K |
| 2026-03-02 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale [10b5-1] | 3.5K | $144.04 | $501K |
| 2026-03-02 | GILD | GILEAD SCIENCES, INC. | A — Grant or award [10b5-1] | 38.4K | $0.00 | |
| 2026-02-06 | GILD | GILEAD SCIENCES, INC. | S — Open-market sale [10b5-1] | 115.6K | $150.00 | $17.35M |
| 2026-02-06 | GILD | GILEAD SCIENCES, INC. | M — Option exercise [10b5-1] | 115.6K | $66.01 | $7.63M |
| 2026-02-05 | GILD | GILEAD SCIENCES, INC. | F — Tax withholding / forfeiture | 74.5K | $143.28 | $10.67M |
| 2026-02-05 | GILD | GILEAD SCIENCES, INC. | A — Grant or award | 131.7K | $0.00 |
O'Day Daniel Patrick is a corporate insider — currently tracked as Chairman & CEO, Director of GILEAD SCIENCES, INC. (GILD). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 22 open-market sales ($46.83M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live O'Day Daniel Patrick profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.